Seven Fleet Capital Management LP
Q3 2026 13F filing
Updated 6 days ago101 disclosed positions worth $511.7M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CG ONCOLOGY INC | $102M | 1.44M | 19.94% | — |
| 2 | R REVOLUTION MEDICINES INC | $44.5M | 216.9K | 8.70% | — |
| 3 | T TANGO THERAPEUTICS INC | $32.2M | 1.29M | 6.29% | — |
| 4 | C CG ONCOLOGY INC | $31.7M | 446.8K | 6.19% | — |
| 5 | T TANGO THERAPEUTICS INC | $23.5M | 943.1K | 4.60% | — |
| 6 | E ENTERA BIO LTD | $20M | 6.86M | 3.90% | — |
| 7 | L LIQUIDIA CORPORATION | $15.4M | 510.1K | 3.02% | — |
| 8 | P PHARVARIS N V | $15.3M | 482.5K | 2.99% | — |
| 9 | A ARRIVENT BIOPHARMA INC | $13.7M | 451.2K | 2.67% | — |
| 10 | X XENCOR INC | $11.1M | 444.9K | 2.17% | — |
| 11 | R ROIVANT SCIENCES LTD | $10.6M | 290.3K | 2.07% | — |
| 12 | A ABIVAX SA | $9.8M | 99.3K | 1.92% | — |
| 13 | R REVOLUTION MEDICINES INC | $9.8M | 47.7K | 1.91% | — |
| 14 | E ENLIVEN THERAPEUTICS INC | $8.5M | 185.7K | 1.66% | — |
| 15 | M VERADERMICS INC | $8.5M | 70.0K | 1.66% | — |
| 16 | P PHARVARIS N V | $6.9M | 217.6K | 1.35% | — |
| 17 | A AVALO THERAPEUTICS INC | $6.8M | 440.4K | 1.32% | — |
| 18 | P PROTAGONIST THERAPEUTICS INC | $6.4M | 45.7K | 1.26% | — |
| 19 | C CENTURY THERAPEUTICS INC | $6.1M | 4.42M | 1.19% | — |
| 20 | A ASSEMBLY BIOSCIENCES INC | $5.3M | 226.4K | 1.04% | — |
| 21 | A AVALO THERAPEUTICS INC | $5.1M | 332.2K | 1.00% | — |
| 22 | A ASSEMBLY BIOSCIENCES INC | $4.5M | 191.0K | 0.88% | — |
| 23 | A AXSOME THERAPEUTICS INC. | $4.4M | 24.1K | 0.87% | — |
| 24 | S SAGIMET BIOSCIENCES INC | $4.2M | 429.1K | 0.83% | — |
| 25 | ? N/A ZENTALIS PHARMACEUTICALS INC | $4.2M | 1.50M | 0.81% | — |
| 26 | D DEFINIUM THERAPEUTICS INC | $4.1M | 108.6K | 0.81% | — |
| 27 | S SILENCE THERAPEUTICS PLC | $3.8M | 350.0K | 0.75% | — |
| 28 | T TARSUS PHARMACEUTICALS INC | $3.8M | 48.5K | 0.75% | — |
| 29 | I IMMUNIC INC | $3.7M | 687.2K | 0.72% | — |
| 30 | T TAYSHA GENE THERAPIES INC | $3.7M | 750.0K | 0.71% | — |
| 31 | C CYTOKINETICS INC | $3.5M | 53.7K | 0.69% | — |
| 32 | E ENLIVEN THERAPEUTICS INC | $3.5M | 76.3K | 0.68% | — |
| 33 | ? N/A DAMORA THERAPEUTICS INC | $3.4M | 158.4K | 0.66% | — |
| 34 | R RELAY THERAPEUTICS INC | $3.4M | 185.7K | 0.66% | — |
| 35 | Z ZAI LAB LTD | $3.1M | 118.4K | 0.61% | — |
| 36 | P PRAXIS PRECISION MEDICINES I | $3.1M | 10.5K | 0.60% | — |
| 37 | E EDITAS MEDICINE INC | $2.9M | 1.92M | 0.58% | — |
| 38 | ? N/A DAMORA THERAPEUTICS INC | $2.8M | 130.0K | 0.54% | — |
| 39 | E EUPRAXIA PHARMACEUTICALS INC | $2.7M | 296.3K | 0.53% | — |
| 40 | L LIQUIDIA CORPORATION | $2.6M | 86.2K | 0.51% | — |
| 41 | N MINERVA NEUROSCIENCES INC | $2.5M | 754.4K | 0.49% | — |
| 42 | E EUPRAXIA PHARMACEUTICALS INC | $2.5M | 276.0K | 0.49% | — |
| 43 | D DIANTHUS THERAPEUTICS INC | $2.2M | 25.4K | 0.44% | — |
| 44 | A ASCENDIS PHARMA A/S | $2.2M | 9.4K | 0.42% | — |
| 45 | C CYTOMX THERAPEUTICS INC. | $1.9M | 714.0K | 0.38% | — |
| 46 | A ADLAI NORTYE GROUP LTD | $1.9M | 116.2K | 0.36% | — |
| 47 | D DIANTHUS THERAPEUTICS INC | $1.9M | 21.1K | 0.36% | — |
| 48 | ? N/A SUTRO BIOPHARMA INC | $1.6M | 99.9K | 0.31% | — |
| 49 | U UNITED THERAPEUTICS CORP DEL | $1.6M | 2.9K | 0.31% | — |
| 50 | I INVENTIVA SA | $1.5M | 414.3K | 0.30% | — |